Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

  • STATUS
    Recruiting
  • End date
    Dec 18, 2025
  • participants needed
    3000
  • sponsor
    Astellas Pharma Inc
Updated on 18 January 2021
Investigator
Medical Affairs Europe
Primary Contact
Site JP00009 (8.2 mi away) Contact
+46 other location

Summary

The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheumatoid arthritis (RA) treated with peficitinib.

Description

This is a mandatory Post-Marketing Surveillance (PMS) requested by Pharmaceuticals and Medical Devices Agency (PMDA) as a part of the Japan-Risk Management Plan (J-RMP).

Details
Treatment peficitinib
Clinical Study IdentifierNCT03971253
SponsorAstellas Pharma Inc
Last Modified on18 January 2021

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Gender: Male or Female
Do you have any of these conditions: Rheumatoid Arthritis (Pediatric) or Rheumatoid Arthritis?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
All patients with rheumatoid arthritis (RA) treated with peficitinib for the first time

Exclusion Criteria

Not applicable
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet